BioCentury – HHS Secretary Alex Azar has submitted three names to the White House as potential FDA commissioners, say individuals who are familiar with the process of selecting and vetting candidates
Food and Drug Administration (FDA)
The Washington Post – The jockeying over who will be the next Food and Drug Administration commissioner intensified when former agency heads and dozens of health groups urged the nomination of acting FDA chief Norman “Ned” Sharpless.
NPR – The Food and Drug Administration rolled out a proposed rule to require graphic warnings on cigarette packages and tobacco ads with the aim of promoting "greater public understanding of the negative health consequences of smoking."
BioCentury – Time may be running out on Ned Sharpless’ term as acting FDA commissioner. President Donald Trump must make a decision about the agency's top job by November 1.
The Motley Fool – The World Health Organization made waves earlier this year by publishing its first marijuana review. It might not seem like it, but bureaucrats in Washington, DC, actually want to know what Americans think about the WHO's recommendation.
STAT – The recent flurry of news about the inclusion of faulty data in the regulatory submission for Zolgensma (onasemnogene abeparvovec-xioi), should remind us all of the FDA’s central role as we grapple with the critical issue of scientific integrity.
The Washington Post – The Food and Drug Administration on Wednesday approved a new drug for highly drug-resistant tuberculosis, the world’s leading infectious cause of death.
Reuters – The U.S. Food and Drug Administration has told four companies to remove 44 of their flavored e-liquid and hookah tobacco products that do not have the required approval for sale in the U.S., the agency said on Thursday.
CNN – The US Food and Drug Administration has received 127 reports of seizures or other neurological symptoms possibly related to e-cigarettes, the agency announced Wednesday.
FDA – On May 24, the FDA approved Zolgensma, a gene therapy product intended to treat children with spinal muscular atrophy (SMA). Following the FDA’s approval of the product, the agency was informed by AveXis Inc., the product’s manufacturer, about a data manipulation issue that impacts the accuracy of certain data.
CNBC – Beyond Meat’s rival Impossible Foods said Wednesday it will sell its plant-based burger in grocery stores in September after the Food and Drug Administration approved its key color ingredient.
CNBC – The FDA told the cannabis company earlier this week that it was “illegally selling” CBD products with “unsubstantiated claims” that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety.